Medicare price of Ramucirumab

Ramucirumab (Ramucirumab) is an anti-tumor agent and a direct VEGFR2 (vascular endothelial growth factor receptor 2) antagonist that blocks the binding of natural VEGF ligands secreted by solid tumors to promote angiogenesis and enhance tumor blood supply. It is used to treat gastric or gastroesophageal junction adenocarcinoma, non-small cell lung cancer, colorectal cancer, and hepatocellular carcinoma. The original drug of ramucizumab has been launched in China, but it has been on the market for a short time and has not been included in the medical insurance. The price of 100mg/10mL box may be around 5,000 yuan, and the price of 500mg/50mL box may be around 17,000 yuan.